2013
DOI: 10.4317/medoral.18373
|View full text |Cite
|
Sign up to set email alerts
|

Use of autologous conditioned serum (Orthokine) for the treatment of the degenerative osteoarthritis of the temporomandibular joint. Review of the literature

Abstract: Objectives: Treatment of osteoarthritis (OA) using autologous conditioned serum (ACS) has become in recent years an alternative to consider in the approach of the degenerative joint disease of the knee. There is no support in the literature for the use of ACS for the treatment of OA of the temporomandibular joint (TMJ), although the promising results obtained in human patients with knee joint disease as well as in animal studies are opening the way for its use at the TMJ. The aim of this paper is to conduct a … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
20
0
2

Year Published

2015
2015
2022
2022

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 23 publications
(22 citation statements)
references
References 15 publications
0
20
0
2
Order By: Relevance
“…PRP can improve bone formation in surgically induced severe degenerative changes of TMJ in rabbits but shows no marked effect on repairing cartilage degradation, and the long-term benefits remain unclear (Kütük et al 2014). Autologous conditioned serum (ACS) as a source of IL-1 receptor antagonist (IL-1Ra) promotes the repair of cartilage and subchondral bone of the knee joint and is an alternative therapy for degenerative joint disease of the knee; however, no reports exist on the use of ACS in the TMJ (Alvarez-Camino et al 2013). The effect of ACS on TMJOA warrants evaluation because IL-1β also plays an important role in the initiation and progression of TMJOA.…”
Section: Cytokine-based Therapymentioning
confidence: 99%
“…PRP can improve bone formation in surgically induced severe degenerative changes of TMJ in rabbits but shows no marked effect on repairing cartilage degradation, and the long-term benefits remain unclear (Kütük et al 2014). Autologous conditioned serum (ACS) as a source of IL-1 receptor antagonist (IL-1Ra) promotes the repair of cartilage and subchondral bone of the knee joint and is an alternative therapy for degenerative joint disease of the knee; however, no reports exist on the use of ACS in the TMJ (Alvarez-Camino et al 2013). The effect of ACS on TMJOA warrants evaluation because IL-1β also plays an important role in the initiation and progression of TMJOA.…”
Section: Cytokine-based Therapymentioning
confidence: 99%
“…The literature furnishes extensive evidence of effec tive use of the Orthokine therapy in degenerative changes of the knee, where it successfully inhibits the inflammatory response of the joint in the form of effusion and synovial membrane proliferation and effects a considerable reduction in pain in follow-up periods lasting up to 2 years [7,8,9,10].…”
Section: Ma Te Riał I Me To Dymentioning
confidence: 99%
“…Due to the very high concentration of growth factors, the method is useful in the treatment of intramuscular injuries, elbow enthesopathy, rotator cuff and Achilles tendon tendinopathy and even in the symptomatic treatment of inflammation of small joints of the hands, feet or the temporomandibular joint [13].…”
Section: Ma Te Riał I Me To Dymentioning
confidence: 99%
See 2 more Smart Citations